Ovarian Cancer Trial, Recruiting (NCT07298564)

Ovarian Cancer Trial, Recruiting NCT07298564 Sponsor: Behnood Abbasi Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07298564 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 19 and 65 years
People who have been diagnosed with polycystic ovary syndrome (PCOS) using a specific set of medical guidelines known as the Rotterdam criteria (confirm with trial site)

Who may not be able to join:

People who have an underactive thyroid (hypothyroidism)
People who have gone through menopause
People who are currently pregnant or breastfeeding
People who have kidney problems or reduced kidney function
People who are currently taking vitamin or mineral supplements as part of a treatment plan
People who have liver conditions, such as advanced fatty liver disease, hepatitis, or cirrhosis
People who have a psychiatric condition such as bipolar disorder
People who have a neuromuscular condition, such as myasthenia gravis, Parkinson's disease, multiple sclerosis, epilepsy, or muscular dystrophy
People who have a history of seizures
People who become pregnant during the study, or who are unable to follow the study plan for more than 20% of the time, would be withdrawn from the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +9821 44864929

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07298564

Sponsor: Behnood Abbasi

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +9821 44864929

More information: https://clinicaltrials.gov/study/NCT07298564

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 19 and 65 years
People who have been diagnosed with polycystic ovary syndrome (PCOS) using a specific set of medical guidelines known as the Rotterdam criteria (confirm with trial site)

Who may not be able to join:

People who have an underactive thyroid (hypothyroidism)
People who have gone through menopause
People who are currently pregnant or breastfeeding
People who have kidney problems or reduced kidney function
People who are currently taking vitamin or mineral supplements as part of a treatment plan
People who have liver conditions, such as advanced fatty liver disease, hepatitis, or cirrhosis
People who have a psychiatric condition such as bipolar disorder
People who have a neuromuscular condition, such as myasthenia gravis, Parkinson's disease, multiple sclerosis, epilepsy, or muscular dystrophy
People who have a history of seizures
People who become pregnant during the study, or who are unable to follow the study plan for more than 20% of the time, would be withdrawn from the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Behnood Abbasi

Registry

ClinicalTrials.gov

Start date

30 January 2026

Est. completion

30 October 2026

Where this trial is recruiting

Iran

Primary endpoints

Change from Baseline of FBS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov